loader
Please Wait
Applying Filters...

Approved Marketing Authorisations (MA) of Orpha Swiss in Europe aggregated by PharmaCompass

Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Ambrisentanum

02 3Anagrelidum

03 4Cefepimum

04 1Naltrexoni hydrochloridum

05 1Ornidazolum

06 1Ropeginterferon alfa-2b

07 1Tadalafilum

08 4Treprostinilum

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass
Left Arrow
Right Arrow

01

Brand Name : Ambrisentan OrPha

Discovery on Target
Not Confirmed
arrow

Brand Name : Ambrisentan OrPha

arrow
Discovery on Target
Not Confirmed

OrPha Swiss

Dosage Form : Filmtabl

Dosage Strength : 10mg

Packaging :

Brand Name : Ambrisentan OrPha

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

02

Brand Name : Ambrisentan OrPha

Discovery on Target
Not Confirmed
arrow

Brand Name : Ambrisentan OrPha

arrow
Discovery on Target
Not Confirmed

OrPha Swiss

Dosage Form : Filmtabl

Dosage Strength : 5mg

Packaging :

Brand Name : Ambrisentan OrPha

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

03

Brand Name : Thromboreductin

Discovery on Target
Not Confirmed
arrow

Brand Name : Thromboreductin

arrow
Discovery on Target
Not Confirmed

OrPha Swiss

Dosage Form : Kaps

Dosage Strength : 0.5mg

Packaging :

Brand Name : Thromboreductin

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

04

Brand Name : Thromboreductin

Discovery on Target
Not Confirmed
arrow

Brand Name : Thromboreductin

arrow
Discovery on Target
Not Confirmed

OrPha Swiss

Dosage Form : Kaps

Dosage Strength : 0.5mg

Packaging :

Brand Name : Thromboreductin

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

05

Brand Name : Thromboreductin

Discovery on Target
Not Confirmed
arrow

Brand Name : Thromboreductin

arrow
Discovery on Target
Not Confirmed

OrPha Swiss

Dosage Form : Kaps

Dosage Strength : 1mg

Packaging :

Brand Name : Thromboreductin

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

06

Brand Name : Cefepime OrPha

Discovery on Target
Not Confirmed
arrow

Brand Name : Cefepime OrPha

arrow
Discovery on Target
Not Confirmed

OrPha Swiss

Dosage Form : Dry Sub

Dosage Strength : 1g

Packaging :

Brand Name : Cefepime OrPha

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

07

Brand Name : Cefepime OrPha

Discovery on Target
Not Confirmed
arrow

Brand Name : Cefepime OrPha

arrow
Discovery on Target
Not Confirmed

OrPha Swiss

Dosage Form : Dry Sub

Dosage Strength : 2g

Packaging :

Brand Name : Cefepime OrPha

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

08

Brand Name : Cefepime OrPha

Discovery on Target
Not Confirmed
arrow

Brand Name : Cefepime OrPha

arrow
Discovery on Target
Not Confirmed

OrPha Swiss

Dosage Form : Dry Sub

Dosage Strength : 1g

Packaging :

Brand Name : Cefepime OrPha

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

09

Brand Name : Cefepime OrPha

Discovery on Target
Not Confirmed
arrow

Brand Name : Cefepime OrPha

arrow
Discovery on Target
Not Confirmed

OrPha Swiss

Dosage Form : Dry Sub

Dosage Strength : 2g

Packaging :

Brand Name : Cefepime OrPha

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

10

Brand Name : Naltrexin

Discovery on Target
Not Confirmed
arrow

Brand Name : Naltrexin

arrow
Discovery on Target
Not Confirmed

OrPha Swiss

Dosage Form : Filmtabl

Dosage Strength : 50mg

Packaging :

Brand Name : Naltrexin

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank